©The Author(s) 2018.
World J Gastroenterol. Jul 14, 2018; 24(26): 2902-2914
Published online Jul 14, 2018. doi: 10.3748/wjg.v24.i26.2902
Published online Jul 14, 2018. doi: 10.3748/wjg.v24.i26.2902
Table 5 Results of individual trials comparing band ligation with other interventions in terms of mortality
| Study (reference) | Treatment | Mean hospitalization days(range or ± SD) | Mortality rate(%) | Follow up (range or ± SD) |
| Endoscopic band ligation vs endoscopic sclerotherapy | ||||
| Luz et al[26] | EBL | NR | 13.60 | 5 d |
| EST | 7.70 | 5 d | ||
| Mansour et al[27] | EBL | NR | No difference | 6 mo |
| EBL + EST | ||||
| Endoscopic band ligation vs endoscopic band ligation + endoscopic sclerotherapy | ||||
| Chen et al[28] | EBL | NR | 2.10 | 6 mo |
| EBL + EST | 6.30 | |||
| Endoscopic band ligation vs β-blockers | ||||
| Stanley et al[30] | EBL | NR | 51.60 | 26.3 mo |
| Carvedilol | 27.30 | |||
| Endoscopic band ligation + β-blockers vs β-blockers | ||||
| Hanif et al[29] | EBL + propranolol | NR | NR | 6 mo |
| Propranolol | ||||
| Endoscopic band ligation + PPIs vs endoscopic band ligation + vasoconstrictors | ||||
| Lo et al[31] | EBL + vasoconstrictors | 9.4 ± 2.3 | 6.7 at 42 d | 42 d |
| EBL + PPIs | 8.8 ± 3.8 | 5.2 at 42 d | ||
| Endoscopic band ligation + β-blockers vs TIPS | ||||
| Holster et al[32] | EBL + β-blockers | 8.8 ± 5.4 | 20 at 2 yr | 23.4 mo |
| TIPS | 12.4 ± 11.2 | 22 at 2 yr | ||
| Lv et al[33] | EBL + propranolol | NR | 12 at 6 mo 12 at 12 mo 16 at 24 mo 33 at 30.4 mo | 30.4 mo |
| TIPS | 16 at 6 mo 17 at 12 mo 27 at 24 mo 33 at 30.9 mo | 30.9 mo | ||
| Endoscopic band ligation vs cyanoacrylate injection | ||||
| Santos et al[34] | EBL | NR | 55 | 338 ± 189 d |
| CI | 56 | |||
| Endoscopic band ligation + endoscopic sclerotherapy vs endoscopic band ligation + microwave coagulation | ||||
| Monici et al[35] | EBL + EST | NR | 5.50 | 36.1 (15-53) mo |
| EBL + MC | 5.88 | 33.6 (14-54) mo | ||
- Citation: Aggeletopoulou I, Konstantakis C, Manolakopoulos S, Triantos C. Role of band ligation for secondary prophylaxis of variceal bleeding. World J Gastroenterol 2018; 24(26): 2902-2914
- URL: https://www.wjgnet.com/1007-9327/full/v24/i26/2902.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i26.2902